BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2016
View Archived Issues
Shionogi recaps events of second quarter of fiscal 2016
Read More
Daiichi Sankyo reflects on achievements of second quarter of fiscal 2016
Read More
Eisai reviews pipeline highlights of second quarter of fiscal 2016
Read More
Sanofi offers overview of active third quarter 2016
Read More
Givinostat significantly counteracts histological disease progression in boys with DMD
Read More
Promising phase I/II results for PR1 peptide vaccine in patients with myeloid malignancies
Read More
Ruijin Hospital, Brandeis University and Xiamen University patent protein kinase inhibitors
Read More
Jiangsu Hengrui Medicine discloses IDO1 and/or TDO inhibitors
Read More
FDA awards orphan drug designation to Amryt's AP-102
Read More
FDA advisory committee votes on solithromycin submission for CABP
Read More
FDA approves Enbrel to treat children with moderate to severe plaque psoriasis
Read More
Genentech and Roche describe NMDA receptor modulators
Read More
Zucara Therapeutics receives investment from Canadian partners
Read More
University of British Columbia develops ERalpha antagonists
Read More
Researchers report new T2D risk loci in Jordan subpopulations
Read More
Cancer Research UK signs agreement with TYG Oncology
Read More
Pulmocide's PC-945 shows efficacy in mice
Read More
Apogenix achieves additional milestones under CANbridge Life Sciences deal
Read More
AdAlta and XL-protein collaborate to develop long-acting form of AD-114
Read More
Onxeo reports increased potency for Livatag compared with free doxorubicin
Read More
FDA grants orphan drug designation to veliparib
Read More
DCC mutations are associated with isolated ACC
Read More
MERIT study of macitentan in CTEPH meets primary endpoint
Read More
Aimmune Therapeutics wins equity investment from Nestle Health Science
Read More
Bayer seeks approvals for regorafenib in second-line HCC in U.S., E.U. and Japan
Read More
FDA clears IND for phase II trial of elafibranor in PBC
Read More
Bevacizumab-800CW tracer safe and tumor specific in cancer patients
Read More
Sandoz files application for approval of GP-2013 in Japan
Read More
EMA accepts MAA from Celltrion for CT-P6
Read More